Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism - Comparison with high density lipoprotein-mediated reverse cholesterol transport

被引:205
|
作者
Babiker, A
Andersson, O
Lund, E
Xiu, RJ
Deeb, S
Reshef, A
Leitersdorf, E
Diczfalusy, U
Bjorkhem, I
机构
[1] KAROLINSKA INST,DEPT MED LAB SCI & TECHNOL,SE-14186 HUDDINGE,SWEDEN
[2] KAROLINSKA INST,CLIN RES CTR,SE-14186 HUDDINGE,SWEDEN
[3] KAROLINSKA INST,DEPT LUNG MED,SE-14186 HUDDINGE,SWEDEN
[4] HADASSAH UNIV HOSP,DIV MED,CTR RES PREVENT & TREATMENT ATHEROSCLEROSIS,IL-91120 JERUSALEM,ISRAEL
关键词
D O I
10.1074/jbc.272.42.26253
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cultured macrophages and endothelial cells have been reported to secrete 27-oxygenated metabolites of cholesterol, This mechanism was compared with the classical high density lipoprotein (HDL)-dependent reverse cholesterol transport, Under standard conditions, macrophage preparations had considerably higher capacity to secrete 27-hydroxycholesterol and 3 beta-hydroxy-5-cholestenoic acid than had endothelial cells and fibroblasts, Western blotting showed that lung macrophages contained the most sterol 27-hydroxylase protein of the cells tested, The relative amounts of 3 beta-hydroxy-5-cholestenoic acid produced by the macrophages were also highest, Macrophages derived from monocytes of patients with sterol 27-hydroxylase deficiency did not secrete 27-oxygenated products, demonstrating that sterol 27-hydroxylase is the critical enzyme for the conversion of cholesterol into the 27-oxygenated steroids, That sterol 27-hydroxylase is responsible not only for 27-hydroxylation of cholesterol but also for time further oxidation of this steroid into 3 beta-hydroxy-5-cholestenoic acid was shown with use of tritium-labeled 27-hydroxy-cholesterol and an inhibitor of sterol 27-hydroxylase. Secretion of 27-oxygenated products by the cultured macrophages as well as the ratio between the alcohol and the acid appeared to be dependent upon total 27-hydroxylase activity, the availability of substrate cholesterol, and the presence of an acceptor for 27-hydroxy-cholesterol in the medium, With albumin as extracellular acceptor, the major secreted product was 3 beta-hydroxy-5-cholestenoic acid. Under such conditions, secretion of labeled 27-oxygenated products was higher than that of labeled cholesterol from lung alveolar macrophages preloaded with [4-C-14]cholesterol. With HDL as acceptor, 27-hydroxycholesterol was the major secreted product, and the total secretion of labeled 27-oxygenated products was only about 10% of that of labeled cholesterol, Thus, 27-hydroxycholesterol and cholesterol may compete for HDL-mediated efflux from the cells. The results support the contention that the sterol 27-hydroxylase-mediated elimination of cholesterol is more important in macrophages than in endothelial cell. This mechanism may be an alternative and/or a complement to the classical HDL-mediated reverse cholesterol transport in macrophages, in particular when the concentration of HDL is low.
引用
收藏
页码:26253 / 26261
页数:9
相关论文
共 50 条
  • [31] High-density lipoprotein metabolism and reverse cholesterol transport: strategies for raising HDL cholesterol
    Trajkovska, Katerina Tosheska
    Topuzovska, Sonja
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2017, 18 (02): : 149 - 154
  • [32] Lipoprotein cholesterol uptake mediates up-regulation of bile-acid synthesis by increasing cholesterol 7α-hydroxylase but not sterol 27-hydroxylase gene expression in cultured rat hepatocytes
    Post, Sabine M.
    Twisk, Jaap
    van der Fits, Leslie
    de Wit, Elly C.M.
    Hoekman, Marco F.M.
    Mager, Willem H.
    Princen, Hans M.G.
    Biochemical Journal, 341 (02): : 339 - 346
  • [33] PROBUCOL, HIGH-DENSITY LIPOPROTEIN METABOLISM AND REVERSE CHOLESTEROL TRANSPORT
    GWYNNE, JT
    AMERICAN JOURNAL OF CARDIOLOGY, 1988, 62 (03): : B48 - B51
  • [34] High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
    Fisher, Edward A.
    Feig, Jonathan E.
    Hewing, Bernd
    Hazen, Stanley L.
    Smith, Jonathan D.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (12) : 2813 - 2820
  • [35] High-density lipoprotein heterogeneity and function in reverse cholesterol transport
    Rothblat, George H.
    Phillips, Michael C.
    CURRENT OPINION IN LIPIDOLOGY, 2010, 21 (03) : 229 - 238
  • [36] High-density lipoprotein-mediated cholesterol efflux from cells is a strong independent predictor of cardiovascular risk
    Chirinos, JA
    Zambrano, JP
    Chakko, SC
    Schob, A
    Perez, GO
    Mendez, AJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 463A - 463A
  • [37] Update on the Role of Endothelial Lipase in High-Density Lipoprotein Metabolism, Reverse Cholesterol Transport, and Atherosclerosis
    Yasuda, Tomoyuki
    Ishida, Tatsuro
    Rader, Daniel J.
    CIRCULATION JOURNAL, 2010, 74 (11) : 2263 - 2270
  • [38] Familial massive tendon xanthomatosis with decreased high-density lipoprotein-mediated cholesterol efflux
    Matsuura, F
    Hirano, K
    Koseki, M
    Ohama, T
    Matsuyama, A
    Tsujii, K
    Komuro, R
    Nishida, M
    Sakai, N
    Hiraoka, H
    Nakamura, T
    Yamashita, S
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (08): : 1095 - 1101
  • [39] High-density lipoprotein-cholesterol, reverse cholesterol transport, and cardiovascular risk: a tale of genetics?
    Cimmino, Giovanni
    D'Amico, Chiara
    Ciccarelli, Giovanni
    Golino, Marco
    Morello, Alberto
    D'Elia, Saverio
    Marchese, Valeria
    Golino, Paolo
    CARDIOGENETICS, 2013, 3 (01) : 38 - 43
  • [40] Role of Phospholipid Transfer Protein in High-Density Lipoprotein- Mediated Reverse Cholesterol Transport
    Yazdanyar, Amirfarbod
    Yeang, Calvin
    Jiang, Xian-Cheng
    CURRENT ATHEROSCLEROSIS REPORTS, 2011, 13 (03) : 242 - 248